biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by bugation May 01, 2014 9:18pm

112 Views

Post# 22515576

RE:RE:RE:RE:RE:RE:Dinx Jinx Mouse Pain Studies

Observer nice try you bozo.
Atleast try to be original with your posts - instead of trying to copy everyone else on this board.

I highly doubt you had any intelligent conversations with anybody. Intelligence and you can not be phrased in the same sentence together.

Go back to your hole twirp.

Bullboard Posts

Gold vs. bitcoin, where should you invest?